HOUSE 1349119th CongressReferred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Women’s Protection in Telehealth Act
- Last Action
- 2/13/2025
Actions
- 2025-02-13Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-02-13Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2025-02-13Introduced in House
- 2025-02-13Introduced in House
CRS Summary
As of 2025-02-13 (00)
Women’s Protection in Telehealth Act
This bill excludes providers of abortion-inducing drugs from participating in Medicare unless the provider is a physician who physically examines the patient, is physically present when the drug is administered, and schedules an in-person follow-up visit with the patient within 14 days of administering the drug.
Cosponsors (7)
- Claudia Tenney (R-NY)
- Mike Haridopolos (R-FL)
- John McGuire (R-VA)
- Andy Biggs (R-AZ)
- Sheri Biggs (R-SC)
- Gus Bilirakis (R-FL)
- Barry Moore (R-AL)
Subjects
- Abortion
- Computers and information technology
- Drug therapy
- Health care coverage and access
- Health technology, devices, supplies
- Medicare
- Prescription drugs
- Women's health
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.